Genetics and cardiovascular disease: Design and development of a DNA biobank

Experimental and Clinical Cardiology

Volumn 14, Issue 3, 2009, Pages 33-37

  Jayasinghe, Satyajit Rohan ^a,b   Mishra, Akshay ^a   Van Daal, Angela ^b   Kwan, Edmond ^b  

^a GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^b BOND UNIVERSITY   (Australia)

Author keywords

Cardiovascular diseases; Genetic biobank; Single nucleotide polymorphisms

Indexed keywords

GENOMIC DNA; MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2A; PLASMINOGEN ACTIVATOR INHIBITOR 2; THROMBOSPONDIN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ARTERY CALCIFICATION; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHROMOSOME ANALYSIS; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FAMILY HISTORY; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HUMAN; MEDICAL ETHICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 74549215647     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002:II-19.
2. Pohjola-Sintonen S, Rissanen A, Liskola P, Luomanmaki K. Family history as a risk factor of coronary heart disease in patients under 60 years of age. Eur Heart J 1998;19:235-9.
3. Rissanen AM, Nikkila EA. Coronary artery disease and its risk factors in families of young men with angina pectoris and in controls. Br Heart J 1977;39:875-83.
4. Thomas CB, Cohen BH. The familial occurrence of hypertension and coronary artery disease with observations concerning obesity and diabetes. Ann Intern Med 1955;42:90-127.
5. Barret-Connor E, Khaw K. Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation 1984;69:1065-9.
6. Shea S, Ottman R, Gabrieli C. Family history as an independent risk factor for coronary heart disease. J Am Coll Cardiol 1984;4:793-801.
7. Hopkins PN, William RR, Kuida H, et al. Family history as an independent risk factor for incident coronary heart disease in high-risk cohort in Utah. Am J Cardiol 1988;62:703-7.
8. Colditz GA, Rimm EB, Giovannucci E, Stampfer MJ, Rosner B, Willett WC. A prospective study of parental history of myocardial infarction and coronary artery disease in men. Am J Cardiol 1991;67:933-8.
9. Scheuner MT. Genetic evaluation for coronary artery disease. Genet Med 2003;5:269-85.
10. Pollex RL, Hegele RA. Copy number variation in the human genome and its implications for cardiovascular disease. Circulation 2007;115:3130-8.
11. Goldstein D. Islands of linkage disequilibrium. Nat Genet 2001;29:109-11.
12. Cardon L, Abecasis G. Using haplotype blocks to map human complex trait loci. Trends Genet 2003;3:135-40.
13. International HapMap Consortium.The International HapMap Project. Nature 2003;426:789-96.
14. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
15. Gitter DM. Resolving the open source paradox in biotechnology: A proposal for a revised open source policy for publicly funded genomic databases. Houston Law Review 2007;43. 〈http://ssrn.com/abstract=901994〉 (Version current at August 12, 2009).
16. Donahue MP, Allen AS, Durham NC. Genetic association studies in cardiology. Am Heart J 2005;149:964-70.
17. Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease N Engl J Med 2007;357:443-53.
18. McCarthy JJ, Parker A, Salem R, et al. Large scale association analysis for identification of genes underlying premature coronary heart disease: Cumulative perspective from analysis of 111 candidate genes. J Med Genet 2004; 41:334-41.
19. Wang L, Topol SE, Topol EJ, Wang Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 2003;302:1578-81.
20. Lieb W, Mayer B, König IR, et al. Lack of association between the MEF2A gene and myocardial infarction. Circulation 2008;117:185-91.
21. Topol EJ. Genomic basis of myocardial infaction. J Am Coll Cardiol 2005;46:1456-65.
22. Pajukanta P, Cargill M, Vittanen LP, et al. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet 2000;67:1481-93.
23. Francke S, Manraj M, Lacquemant C, et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet 2001;10:2751-65.
24. Broeckel U, Hengstenberg C, Mayer B, et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 2002;30:210-4.
25. Harrap SB, Zammit KS, Wong ZY, et al. Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler Thromb Vasc Biol 2002;22:874-8.
26. LangeLA, Lange EM, Bielak LF, et al. Autosomal genome-wide scan for coronary artery calcification loci in sibships at high risk for hypertension. Arterioscler Thromb Vasc Biol 2002;22:418-23.
27. Sturm AC. Cardiovascular genetics: Are we there yet? J Med Genet 2004;41:321-3.
28. Christensen K, Murray JC. What genome-wide association studies can do for medicine. N Engl J Med 2007;356:1094-7.
29. Cooper DN, Nussabaum RL, Krawxzak M. Proposed guidelines for papers describing DNA polymorphism-disease associations. Hum Genet 2002;110:207-8.
30. Haddow G, Cunningham-Burley S, Bruce A, Parry S. Generation Scotland: Consulting publics and specialists at an early stage in a genetic database's development.Critical Public Health 2008;18:139-49.
31. Frank L. Storm brews over gene bank of Estonian population. Science 1999;286:1262-3.
32. Williams C. Australian attitudes to DNA sample banks and genetic screening. Curr Med Res Opin 2005; 21:1773-5.
33. The Baker IDI Biobank. 〈http://www.bakeridi.edu.au/〉 (Version current at April 10, 2009).
34. Voelker R. Two generations of data aid Framingham's focus on genes. JAMA 1998;279:1245-6.
35. Abbott A. Iceland's doctors rebuffed in health data row. Nature 2000;406:819.
36. Petersen A. Securing our genetic health: Engendering trust in UK Biobank. Sociol Health Illn 2005;27:271-92.
37. Rosell S. Sweden's answer to genomics ethic. Nature 1999;401:208.
38. Gulcher JR, Stefansson K. Ethics of population genomics research. Nature 1999;400:307-8.